ArticleScientific reports2022

Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.

Shigehiro Tsukahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.